Topical glaucoma medications and cardiovascular risk in the elderly.
To determine the frequency of congestive heart failure and cardiac conduction disturbances in elderly patients treated with topical glaucoma medications.
These case-control studies were conducted among participants in the New Jersey Medicaid and Medicare program from 1986 to 1990.
A total of 35,445 subjects (ages 65 to 99 years) were included in the congestive heart failure analysis, and 4278 subjects were included in the conduction disorder analysis.
The frequency of initiation of congestive heart failure therapy, defined as the new use of digoxin or furosemide, was not increased for users of topical glaucoma medications.
The frequency of pacemaker placement was also not increased for topical glaucoma medication users.
Mots-clés Pascal : Antiglaucomateux, Toxicité, Voie locale, Trouble conduction, Insuffisance cardiaque, Facteur risque, Vieillard, Homme, Epidémiologie, New Jersey, Etats Unis, Amérique du Nord, Amérique, Glaucome, Oeil pathologie, Appareil circulatoire pathologie, Cardiopathie
Mots-clés Pascal anglais : Antiglaucomatous agent, Toxicity, Local administration, Conduction disorder, Heart failure, Risk factor, Elderly, Human, Epidemiology, New Jersey, United States, North America, America, Glaucoma (eye), Eye disease, Cardiovascular disease, Heart disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0203234
Code Inist : 002B02M. Création : 199406.